Pulmonary Hemorrhaging Caused by Acute Severe Mitral Regurgitation during Transcatheter Aortic Valve Implantation

Transcatheter aortic valve implantation (TAVI) has been validated as a reliable therapy for aortic stenosis (AS), similar to surgical aortic valve replacement. Due to the methodological differences between the two therapeutic options, each has unique complications. We experienced a hitherto unreport...

Full description

Saved in:
Bibliographic Details
Published in:Internal Medicine Vol. 57; no. 8; pp. 1115 - 1117
Main Authors: Higuchi, Ryosuke, Tobaru, Tetsuya, Saji, Mike, Mahara, Keitaro, Takamisawa, Itaru, Shimizu, Jun, Takanashi, Shuichiro, Takayama, Morimasa
Format: Journal Article
Language:English
Published: Japan The Japanese Society of Internal Medicine 01-01-2018
Japan Science and Technology Agency
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Transcatheter aortic valve implantation (TAVI) has been validated as a reliable therapy for aortic stenosis (AS), similar to surgical aortic valve replacement. Due to the methodological differences between the two therapeutic options, each has unique complications. We experienced a hitherto unreported complication of TAVI. An 81-year-old man underwent TAVI for severe AS. Acute mitral regurgitation (MR) occurred during valve deployment. Interference of the guidewire with the mitral subvalvular structure caused transient severe MR, leading to the development of pulmonary hemorrhaging. During TAVI, careful attention should be paid to the position of the guidewire, changes in hemodynamics and degree of MR.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
Correspondence to Dr. Ryosuke Higuchi, rhiguchi@shi.heart.or.jp
ISSN:0918-2918
1349-7235
DOI:10.2169/internalmedicine.9712-17